Volume 89, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In central China, accounts for all of the native reported cases of malaria. Chloroquine (CQ) plus primaquine (PQ) have been used for more than 60 years as the frontline drugs, but the risk of treatment failure remains unknown. To measure the effectiveness and safety of CQ-PQ among vivax malaria patients, a total of 39 subjects with monoinfection vivax malaria was enrolled in a study from 2008 to 2009. There were no recrudescence or danger signs observed within the 28-day follow-up period, showing that blood stage of isolates from central China is still susceptible to CQ plus PQ combination therapy. However, the antirelapse efficacy of PQ is difficult to assess because of the high rate of loss to follow-up after 28 days; also, parasites persisted in a single case at 3 days post-antimalarial drug treatment, indicating that continuous annual monitoring is needed in central China.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. WHO, 2011. World Malaria Report 2011. Available at: http://www.who.int/malaria/world_malaria_report_2011/9789241564403_eng.pdf. Accessed February 2012. [Google Scholar]
  2. Tang YE, Zhong CY, Jiang CB, Wang WM, , 2011. Results of surveillance of malaria in Suining County. China Trop Med 11: 5051. [Google Scholar]
  3. Zhang W, Wang L, Fang L, Ma J, Xu Y, Jiang J, Hui F, Wang J, Liang S, Yang H, Cao W, , 2008. Spatial analysis of malaria in Anhui province, China. Malar J 7: 206.[Crossref] [Google Scholar]
  4. Zhou SS, Wang Y, Tang LH, , 2007. Malaria situation in the People's Republic of China in 2006. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 25: 439441. [Google Scholar]
  5. The Ministry of Health of the People's Republic of China, 2010. China Action Plan for Malaria Elimination. Available at: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohjbyfkzj/s3593/201005/47529.htm. Accessed May 2010. [Google Scholar]
  6. Baird JK, , 2004. Chloroquine resistance in Plasmodium vivax . Antimicrob Agents Chemother 48: 40754083.[Crossref] [Google Scholar]
  7. Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, Menard D, , 2008. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother 52: 42334240.[Crossref] [Google Scholar]
  8. de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa MG, Alecrim WD, Alecrim MG, , 2007. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis 13: 11251126.[Crossref] [Google Scholar]
  9. Baird JK, Hoffman SL, , 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 13361345.[Crossref] [Google Scholar]
  10. Zhou SS, Huang F, Wang JJ, Zhang SS, Su YP, Tang LH, , 2010. Geographical, meteorological and vectorial factors related to malaria re-emergence in Huang-Huai River of central China. Malar J 9: 337.[Crossref] [Google Scholar]
  11. White NJ, , 2011. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 10: 297.[Crossref] [Google Scholar]
  12. Editorial Committee of Malaria Control and Research in China, 1991. Malaria Control and Research in China. Beijing, China: People's Medical Publishing House. [Google Scholar]
  13. Lu F, Gao Q, Zhou H, Cao J, Wang W, Lim CS, Na S, Tsuboi T, Han ET, , 2012. Molecular test for vivax malaria with loop-mediated isothermal amplification method in central China. Parasitol Res 110: 24392444.[Crossref] [Google Scholar]
  14. Anstey NM, Russell B, Yeo TW, Price RN, , 2009. The pathophysiology of vivax malaria. Trends Parasitol 25: 220227.[Crossref] [Google Scholar]
  15. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA, , 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555566.[Crossref] [Google Scholar]
  16. Lu F, Wang B, Cao J, Sattabongkot J, Zhou H, Zhu G, Kim K, Gao Q, Han E, , 2012. Prevalence of drug resistance-associated gene mutations of Plasmodium vivax in Central China. Korean J Parasitol 50: 379384.[Crossref] [Google Scholar]
  17. Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, Cui L, Sattabongkot J, , 2011. In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. Am J Trop Med Hyg 85: 197201.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 08 Nov 2012
  • Accepted : 10 Apr 2013
  • Published online : 10 Jul 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error